Revenue for Q1 2026 reached $1.42 billion, a 5% increase compared to $1.35 billion in Q1 2025. Net income attributable to Select Medical Holdings Corporation was $44.0 million, down from $56.7 million in the prior year period. Adjusted EBITDA decreased 6.5% to $141.6 million, with an Adjusted EBITDA margin of 10.0%. Earnings per share (basic and diluted) were $0.35, compared to $0.44 in Q1 2025. The company entered into a definitive merger agreement on March 2, 2026, to be acquired for $16.50 per share in cash. The merger is expected to close in the middle of 2026, subject to regulatory and stockholder approvals.